Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Directors Deals Ltd.
$12.00
Provider: Wright Reports
$150.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanistaal A/S Maintains FY 2013 EBIT Guidance


Tuesday, 21 May 2013 07:32am EDT 

Sanistaal A/S announced that the Company's fiscal year 2013 financial guidance remains unchanged. The Company continues to expect fiscal year 2013 operating profit (EBIT) to be in the range of DKK 110 million and DKK 150 million. 

Company Quote

47.2
-0.3 -0.63%
9:57am EST